Anti-arrhythmic effects of lidocaine metabolites.
D000818:Animals; D000889:Anti-Arrhythmia Agents; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000517:prevention & control*; D004195:Disease Models, Animal; D004341:Drug Evaluation; D005021:Ethylamines / Q000627:therapeutic use; D006168:Guinea Pigs; D006325:Heart Atria / Q000187:drug effects; D008012:Lidocaine / Q000031:analogs & derivatives* / Q000378:metabolism / Q000627:therapeutic use*; D008297:Male; D008744:Methylamines / Q000627:therapeutic use; D010042:Ouabain
D000889:Anti-Arrhythmia Agents; D005021:Ethylamines; D008744:Methylamines; D010042:Ouabain; D008012:Lidocaine